Fr. 72.00

Issledowanie neobhodimosti izmeneniq patentnoj politiki Soedinennyh Shtatow - Issledowanie industrii programmnogo obespecheniq i farmacewticheskoj promyshlennosti

Russian · Paperback / Softback

Shipping usually within 1 to 2 weeks (title will be printed to order)

Description

Read more










Cel'ü dannogo issledowaniq bylo wyqsnit', kak razlichaütsq trebowaniq patentnoj politiki SShA dlq industrii programmnogo obespecheniq i farmacewticheskoj promyshlennosti, a takzhe opredelit', naskol'ko adekwatno patentnaq politika SShA zaschischaet prawa intellektual'noj sobstwennosti (PIS) dlq dwuh razlichnyh otraslej, stimuliruq pri ätom inwesticii w issledowaniq i razrabotki (NIOKR), dostatochnye dlq uwelicheniq pribyli i innowacij. Dannye dlq ätogo issledowaniq sostoqli iz 38 swidetel'skih pokazanij, dannyh w Kongresse SShA w period s 2005 po 2010 god äxpertami, predstawlqüschimi dwe interesuüschie nas otrasli: farmacewticheskuü i programmnuü.

About the author










Doktor Acheson imeet bolee chem 25-letnij opyt raboty w oblasti wzaimodejstwiq s kollektiwom, formirowaniq komandy i liderstwa. Ego issledowatel'skie interesy swqzany s razwitiem innowacij w obschestwe i prepqtstwiqmi na puti innowacij. Osnownoe wnimanie udelqetsq patentnoj politike. V nastoqschee wremq doktor Acheson qwlqetsq chlenom i recenzentom rukopisej Associacii finansowogo menedzhmenta w zdrawoohranenii.

Product details

Authors Kent Acheson
Publisher Sciencia Scripts
 
Languages Russian
Product format Paperback / Softback
Released 14.02.2024
 
EAN 9786207155569
ISBN 9786207155569
No. of pages 132
Subject Natural sciences, medicine, IT, technology > Medicine > Pharmacy

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.